Search Results - "Miller, Claire Prener"

HIGHER PAIN VARIATION DURING THE SCREENING PHASE IS ASSOCIATED WITH A LARGER PLACEBO RESPONSE – POST-HOC ANALYSIS OF A PHASE 2B KNEE OSTEOARTHRITIS TRIAL by Bentin, Jakob M., Miller, Claire Prener, Mondragon, Alejandro Castillo, Adrian, Ida Sofie, Arendt-Nielsen, Lars, Alexandersen, Peter, Bihlet, Asger R.

Get full text

045 - HIGHER PAIN VARIATION DURING THE SCREENING PHASE IS ASSOCIATED WITH A LARGER PLACEBO RESPONSE – POST-HOC ANALYSIS OF A PHASE 2B KNEE OSTEOARTHRITIS TRIAL by Bentin, Jakob M., Miller, Claire Prener, Mondragon, Alejandro Castillo, Adrian, Ida Sofie, Arendt-Nielsen, Lars, Alexandersen, Peter, Bihlet, Asger R.

Get full text

Efficacy and safety of an intra-articular placental tissue particulate (MOTYS/PTP-001) in symptomatic knee osteoarthritis over 26 weeks: A placebo-controlled, double-blind randomized clinical trial by Bihlet, Asger R., Pavesio, Alessandra, Kottke, Mary Kathryn, Miller, Claire Prener, Poudel, Pratiksha, Alexandersen, Peter, Rovsing, Helene, Carbonneau, Diane, Hunter, David

Get full text

065 - Efficacy and safety of an intra-articular placental tissue particulate (MOTYS/PTP-001) in symptomatic knee osteoarthritis over 26 weeks: A placebo-controlled, double-blind randomized clinical trial by Bihlet, Asger R., Pavesio, Alessandra, Kottke, Mary Kathryn, Miller, Claire Prener, Poudel, Pratiksha, Alexandersen, Peter, Rovsing, Helene, Carbonneau, Diane, Hunter, David

Get full text

Transcranial low‐frequency pulsating electromagnetic fields (T‐PEMF) as post‐concussion syndrome treatment by Miller, Claire Prener, Prener, Martin, Dissing, Steen, Paulson, Olaf B.

“…Background Treatment options for the subgroup of people who develop long‐lasting symptoms following mild traumatic brain injury are limited. Transcranial…”
Get full text

EFFICACY OUTCOMES IN PATIENTS WITH KNEE OSTEOARTHRITIS: PER-PROTOCOL ANALYSES FROM SPRINGBOARD, A PHASE 2, RANDOMIZED, 24-WEEK STUDY OF EP-104IAR (LONG-ACTING INTRA-ARTICULAR INJECTION OF FLUTICASONE PROPIONATE) by Helliwell, James A., Malone, Amanda, Kowalski, Mark M., Rovsing, Helene, Boll, Sidsel Lynggard, Bihlet, Asger R., Miller, Claire Prener, Mondragon, Alejandro Castillo, Li, Yanqi, Dobek, Christine, Peck, Vik, Wilmink, Mike, Conaghan, Philip, Simon, Lee S.

Get full text

063 - EFFICACY OUTCOMES IN PATIENTS WITH KNEE OSTEOARTHRITIS: PER-PROTOCOL ANALYSES FROM SPRINGBOARD, A PHASE 2, RANDOMIZED, 24-WEEK STUDY OF EP-104IAR (LONG-ACTING INTRA-ARTICULAR INJECTION OF FLUTICASONE PROPIONATE) by Helliwell, James A., Malone, Amanda, Kowalski, Mark M., Rovsing, Helene, Boll, Sidsel Lynggard, Bihlet, Asger R., Miller, Claire Prener, Mondragon, Alejandro Castillo, Li, Yanqi, Dobek, Christine, Peck, Vik, Wilmink, Mike, Conaghan, Philip, Simon, Lee S.

Get full text

VIVIAD, A Phase 2b Study Investigating Varoglutamstat in Patients with MCI or Mild AD: Analysis of Baseline Cognition Data by Wenzkowski, Christine, Schaeffer, Michael, Fuchs, Katharina, Weber, Frank, Li, Yanqi, Miller, Claire Prener, Bihlet, Asger Reinstrup, Alexandersen, Peter, Axelsen, Tobias Melton, Harrison, John E, Vijverberg, Everard G.B.

“…Background Varoglutamstat (PQ912) is an oral, small molecule inhibitor of glutaminyl cyclase, preventing the formation of neurotoxic N3pE amyloid. A Phase 2a…”
Get full text

Developing Topics by Wenzkowski, Christine, Schaeffer, Michael, Fuchs, Katharina, Weber, Frank, Li, Yanqi, Miller, Claire Prener, Bihlet, Asger Reinstrup, Alexandersen, Peter, Axelsen, Tobias Melton, Harrison, John E, Vijverberg, Everard G B

“…Varoglutamstat (PQ912) is an oral, small molecule inhibitor of glutaminyl cyclase, preventing the formation of neurotoxic N3pE amyloid. A Phase 2a study…”
Get full text